__NUXT_JSONP__("/drugs/Medroxyprogesterone_Acetate", (function(a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,A){return {data:[{drug:{slug:m,emaEpar:[],fdaDrugLabel:[{brand:d,indication:i,manufacturer:n,splSetId:"01e28bef-9758-40cf-a4ff-86ae9f4f5105"},{brand:c,indication:j,manufacturer:g,splSetId:"0930a471-6ff1-43a1-b3ea-948ca3f99d06"},{brand:a,indication:b,manufacturer:o,splSetId:"0df6fd1e-7d9c-4a38-848c-1e562e211c91"},{brand:"Medroxyprogesterone",indication:b,manufacturer:"PharmPak, Inc.",splSetId:"1403a9a9-c04a-432f-8819-4850f779312e"},{brand:p,indication:"1 INDICATIONS AND USAGE Depo-Provera CI is indicated for use by females of reproductive potential to prevent pregnancy. Depo-Provera CI is a progestin indicated for use by females of reproductive potential to prevent pregnancy. ( 1 ) Limitations of Use: The use of Depo-Provera CI is not recommended as a long-term (i.e., longer than 2 years) birth control method unless other options are considered inadequate. ( 1 , 5.1 ) Limitations of Use : The use of Depo-Provera CI is not recommended as a long-term (i.e., longer than 2 years) birth control method unless other options are considered inadequate [see Dosage and Administration (2.1) and Warnings and Precautions (5.1) ].",manufacturer:q,splSetId:"199cf13e-0859-4a73-9b45-e700d0cd1049"},{brand:c,indication:j,manufacturer:g,splSetId:"20c0841f-740c-4d53-af55-938c4e5b09e5"},{brand:c,indication:j,manufacturer:r,splSetId:"2627eb11-06bf-4a45-9172-094468e3ca07"},{brand:a,indication:b,manufacturer:"Preferred Pharmaceuticals, Inc.",splSetId:"37275fd0-eb24-40a4-a93f-b818bb98414e"},{brand:"Depo-SubQ Provera",indication:"1 INDICATIONS AND USAGE Depo-subQ provera 104 is indicated in females of reproductive age for: Prevention of pregnancy and Management of endometriosis-associated pain. Depo-subQ provera 104 is a progestin that is indicated in females of reproductive age for: Prevention of pregnancy. ( 1 ) Management of endometriosis-associated pain. ( 1 ) Limitations of Use : Use of depo-subQ provera 104 is not recommended as a long-term (i.e., longer than 2 years) birth control method or medical therapy for endometriosis-associated pain unless other options are considered inadequate. ( 1 , 5.1 ) Limitations of Use : The use of depo-subQ provera 104 is not recommended as a long-term (i.e., longer than 2 years) birth control method or medical therapy for endometriosis-associated pain unless other options are considered inadequate [see Dosage and Administration (2.1) and Warnings and Precautions (5.1) ].",manufacturer:q,splSetId:"390087a6-f3c3-4f0b-a930-79acf412f153"},{brand:s,indication:t,manufacturer:e,splSetId:"3aff3442-641c-4639-8273-cf0347d8e4c8"},{brand:d,indication:"1 INDICATIONS AND USAGE Medroxyprogesterone acetate injectable suspension is indicated for use by females of reproductive potential to prevent pregnancy. Limitations of Use: The use of medroxyprogesterone acetate injectable suspension is not recommended as a long-term (i.e., longer than 2 years) birth control method unless other options are considered inadequate [see Dosage and Administration ( 2.1 ) and Warnings and Precautions ( 5.1 )]. Medroxyprogesterone acetate is a progestin indicated for use by females of reproductive potential to prevent pregnancy. ( 1 ) Limitations of Use: The use of medroxyprogesterone acetate injectable suspension is not recommended as a long-term (i.e., longer than 2 years) birth control method unless other options are considered inadequate. ( 1 , 5.1 )",manufacturer:"Cipla USA Inc.",splSetId:"3d033fba-6313-4906-9d34-245423eaeeef"},{brand:a,indication:b,manufacturer:"RedPharm Drug, Inc.",splSetId:"419479ee-c1e1-306c-e054-00144ff8d46c"},{brand:c,indication:h,manufacturer:r,splSetId:"428481bb-b7cf-4d76-b57d-0d6bfa2b6ac3"},{brand:a,indication:b,manufacturer:g,splSetId:"437edd12-2c08-4df4-8cf7-64c47e4779ac"},{brand:a,indication:b,manufacturer:l,splSetId:"59cdc070-b4a2-1502-e053-2a91aa0a34fa"},{brand:a,indication:b,manufacturer:l,splSetId:"5c8ffae3-3b3e-197e-e053-2a91aa0a59e3"},{brand:c,indication:h,manufacturer:e,splSetId:"5e817926-ba15-4d16-9463-88f6ff3bd3ac"},{brand:a,indication:"1 INDICATIONS AND USAGE Medroxyprogesterone acetate injectable suspension is indicated for use by females of reproductive potential to prevent pregnancy. Limitations of Use: The use of medroxyprogesterone acetate injectable suspension is not recommended as a long-term (i.e., longer than 2 years) birth control method unless other options are considered inadequate [see Dosage and Administration (2.1) and Warnings and Precautions (5.1) ]. Medroxyprogesterone acetate injectable suspension is a progestin indicated for use by females of reproductive potential to prevent pregnancy. ( 1 ) Limitations of Use: The use of medroxyprogesterone acetate injectable suspension is not recommended as a long-term (i.e., longer than 2 years) birth control method unless other options are considered inadequate. ( 1 , 5.1 )",manufacturer:"Mylan Institutional LLC",splSetId:"60aba812-59eb-4d40-9b6b-d135dca9d36b"},{brand:a,indication:b,manufacturer:g,splSetId:"6a541749-5d14-44aa-a409-5e51f5bbf929"},{brand:a,indication:b,manufacturer:e,splSetId:"788df737-e990-4b5e-accd-af13c3b2bf8b"},{brand:d,indication:u,manufacturer:v,splSetId:"7cc31691-8268-4e59-b645-19246931f03c"},{brand:a,indication:k,manufacturer:l,splSetId:"7cff8b17-0468-68ba-e053-2991aa0af484"},{brand:a,indication:b,manufacturer:e,splSetId:"816b9fd2-bc55-496b-846a-cabe7bbdecd6"},{brand:d,indication:u,manufacturer:"Afaxys Pharma, LLC",splSetId:"908573ce-d494-4f7f-95ae-6edbc4e4c5dc"},{brand:a,indication:b,manufacturer:f,splSetId:"93b7c9e8-fa4a-4b6f-879f-d71fd251e349"},{brand:a,indication:"1 INDICATIONS AND USAGE Medroxyprogesterone Acetate Injectable Suspension is indicated only for the prevention of pregnancy. The loss of bone mineral density (BMD) in women of all ages and the impact on peak bone mass in adolescents should be considered, along with the decrease in BMD that occurs during pregnancy and\u002For lactation, in the risk\u002Fbenefit assessment for women who use Medroxyprogesterone Acetate Injectable Suspension long-term [ see Warnings and Precautions ( 5.1 ) ]. â€¢ Medroxyprogesterone Acetate Injectable Suspension is a progestin indicated only for the prevention of pregnancy. ( 1 )",manufacturer:o,splSetId:"9451ca1a-34a4-46e2-bacc-6268a2f60bc8"},{brand:c,indication:h,manufacturer:"Prasco Laboratories",splSetId:"987496bf-b4b0-409b-b745-f52ed0871f4e"},{brand:a,indication:b,manufacturer:"Teva Pharmaceuticals USA, Inc.",splSetId:"9eb200b0-db96-4a51-87ea-04db862978c8"},{brand:a,indication:b,manufacturer:f,splSetId:"a36c89b7-9463-4d00-a4d3-021d77090077"},{brand:w,indication:"INDICATIONS AND USAGE PROVERA tablets are indicated for the treatment of secondary amenorrhea and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as fibroids or uterine cancer. They are also indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving daily oral conjugated estrogens 0.625 mg tablets.",manufacturer:"Pharmacia and Upjohn Company",splSetId:"a586be28-96af-4fed-a13f-9b94fd4c7405"},{brand:a,indication:k,manufacturer:e,splSetId:"a67023c9-9927-4333-aa88-00804db36570"},{brand:a,indication:b,manufacturer:f,splSetId:"a88b33ff-842b-4a5b-a27e-9c2b9e85a4d7"},{brand:a,indication:b,manufacturer:"Denton Pharma, Inc. dba Northwind Pharmaceuticals",splSetId:"ab82d81a-fb06-ff34-e053-2a95a90a12ef"},{brand:a,indication:b,manufacturer:f,splSetId:"bdb89690-ced2-48e1-bb1a-e5eccfeda8eb"},{brand:a,indication:b,manufacturer:e,splSetId:"bfdf335d-1cbb-4533-9fde-99a9c71f7504"},{brand:a,indication:b,manufacturer:"American Health Packaging",splSetId:"cbf142f9-9af3-4d79-9343-0ab42d6dbe9f"},{brand:a,indication:b,manufacturer:"RPK Pharmaceuticals, Inc.",splSetId:"ceccfb43-ad89-482d-9564-5867df1c936f"},{brand:d,indication:i,manufacturer:n,splSetId:"d1ea4098-6196-421f-b8e1-bcb31a061e04"},{brand:c,indication:h,manufacturer:x,splSetId:"d21979ec-271f-4e4a-8d4d-d561b8a0f563"},{brand:a,indication:y,manufacturer:"Teva Parenteral Medicines, Inc.",splSetId:"d279981c-e9e4-4989-bafb-1e184a6d3dd2"},{brand:c,indication:h,manufacturer:e,splSetId:"d415e7cc-0756-4c70-803f-011133a6b731"},{brand:a,indication:y,manufacturer:f,splSetId:"d4d27703-5ad0-4ead-9481-0aba2fa1b45c"},{brand:a,indication:b,manufacturer:f,splSetId:"d9ad130b-8f9a-4a0f-beb4-b692b6d3c5ca"},{brand:c,indication:j,manufacturer:g,splSetId:"e1d5975a-e0e5-444d-bab0-3904c3f377c9"},{brand:a,indication:k,manufacturer:z,splSetId:"e364a31e-8926-4bda-b00e-efb097bd3830"},{brand:a,indication:b,manufacturer:x,splSetId:"e3dfd683-d44e-427b-af06-70b9b698e016"},{brand:d,indication:i,manufacturer:e,splSetId:"e7cdee68-8d8f-411d-bc65-ddbf31866369"},{brand:d,indication:i,manufacturer:v,splSetId:"f7629f1b-602d-47f9-947d-7ec5bc4ac8d0"},{brand:s,indication:t,manufacturer:"Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.",splSetId:"fd0c0836-5d23-2183-da81-9dc7f4287052"},{brand:a,indication:k,manufacturer:z,splSetId:"fda1aa8a-5739-482a-b4f6-9741ef4d9977"}],id:m,nciThesaurus:{casRegistry:"71-58-9",chebiId:"CHEBI:6716",chemicalFormula:"C24H34O4",definition:"A synthetic, acetate derivative of the sex hormone progesterone.  Medroxyprogesterone 17-acetate",fdaUniiCode:"C2QI4IOI2G",identifier:"C1155",preferredName:a,semanticType:"Organic Chemical",subclassOf:["C776"],synonyms:["(6alpha)-17-(Acetyloxy)-6-methylpregn-4-ene-3,20-dione","17-(Acetyloxy)-6alpha-methylpregn-4-ene-3,20-dione","17-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione Acetate","17Alpha-acetoxy-6alpha-methylprogesterone","6-Alpha-methyl-17alpha-acetoxyprogesterone","Amen","Aragest","Ciclotal","Clinofem","Clinovir","Cycrin","Depo-Clinovir",p,"Depo-provera","Depot-Medroxyprogestereone Acetate","Farlutal","G-Farlutal","Gestapuran","Hysron","Lutoral",d,"MPA","Medroxyprogesterone 17-Acetate",a,"Medroxyprogesterone acetate","Medroxyprogesteroni Acetas","Methylacetoxyprogesterone","Metipregnone","Nadigest","Nadigest (vet)","Nidaxin","Nidaxin (vet)","Oragest","Perlutex","Prodasone",w,"Sodelut G","Veramix",c]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FMedroxyprogesterone_Acetate",extension:".json",createdAt:A,updatedAt:A}}],fetch:{},mutations:void 0}}("Medroxyprogesterone Acetate","INDICATIONS AND USAGE Medroxyprogesterone Acetate Tablets USP are indicated for the treatment of secondary amenorrhea and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as fibroids or uterine cancer. They are also indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving daily oral conjugated estrogens 0.625 mg tablets.","medroxyprogesterone acetate","MEDROXYPROGESTERONE ACETATE","A-S Medication Solutions","Bryant Ranch Prepack","PD-Rx Pharmaceuticals, Inc.","1 INDICATIONS AND USAGE Medroxyprogesterone Acetate (MPA) Injectable Suspension, USP is indicated for use by females of reproductive potential to prevent pregnancy. Medroxyprogesterone Acetate (MPA) Injectable Suspension, USP is a progestin indicated for use by females of reproductive potential to prevent pregnancy. ( 1 ) Limitations of Use : The use of MPA Injectable Suspension, USP is not recommended as a long-term (i.e., longer than 2 years) birth control method unless other options are considered inadequate. ( 1 , 5.1 ) Limitations of Use : The use of MPA Injectable Suspension, USP is not recommended as a long-term (i.e., longer than 2 years) birth control method unless other options are considered inadequate [see Dosage and Administration (2.1) and Warnings and Precautions (5.1) ].","1 INDICATIONS AND USAGE Medroxyprogesterone acetate injectable suspension is indicated for use by females of reproductive potential to prevent pregnancy. Limitations of Use: The use of medroxyprogesterone acetate injectable suspension is not recommended as a long-term (i.e., longer than 2 years) birth control method unless other options are considered inadequate [see Dosage and Administration (2.1) and Warnings and Precautions (5.1)]. Medroxyprogesterone acetate is a progestin indicated for use by females of reproductive potential to prevent pregnancy. (1) Limitations of Use: The use of medroxyprogesterone acetate injectable suspension is not recommended as a long-term (i.e., longer than 2 years) birth control method unless other options are considered inadequate. (1, 5.1)","INDICATIONS AND USAGE Medroxyprogesterone acetate tablets are indicated for the treatment of secondary amenorrhea and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as fibroids or uterine cancer. They are also indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving daily oral conjugated estrogens 0.625 mg tablets.","1 INDICATIONS AND USAGE Medroxyprogesterone acetate is indicated only for the prevention of pregnancy. The loss of bone mineral density (BMD) in women of all ages and the impact on peak bone mass in adolescents should be considered, along with the decrease in BMD that occurs during pregnancy and\u002For lactation, in the risk\u002Fbenefit assessment for women who use Medroxyprogesterone acetate long-term [see Warnings and Precautions (5.1) ] . Medroxyprogesterone acetate is a progestin indicated only for the prevention of pregnancy. ( 1 )","NuCare Pharmaceuticals,Inc.","Medroxyprogesterone_Acetate","Sun Pharmaceutical Industries, Inc.","Proficient Rx LP","Depo-Provera","Pharmacia & Upjohn Company LLC","Greenstone LLC","Prempro","1 INDICATIONS AND USAGE PREMPRO\u002FPREMPHASE is an estrogen plus progestin indicated in a woman with a uterus for: Treatment of Moderate to Severe Vasomotor Symptoms due to Menopause ( 1.1 ) Treatment of Moderate to Severe Vulvar and Vaginal Atrophy due to Menopause ( 1.2 ) Prevention of Postmenopausal Osteoporosis ( 1.3 ) 1.1 Treatment of Moderate to Severe Vasomotor Symptoms due to Menopause 1.2 Treatment of Moderate to Severe Vulvar and Vaginal Atrophy due to Menopause 1.3 Prevention of Postmenopausal Osteoporosis","1 INDICATIONS AND USAGE Medroxyprogesterone acetate injectable suspension for use by females of reproductive potential to prevent pregnancy. Limitations of Use: The use of medroxyprogesterone acetate injectable suspension is not recommended as a long-term (i.e., longer than 2 years) birth control method unless other options are considered inadequate [see Dosage and Administration (2.1) and Warnings and Precautions (5.1)]. Medroxyprogesterone acetate for use by females of reproductive potential to prevent pregnancy. (1) Limitations of Use: The use of medroxyprogesterone acetate injectable suspension is not recommended as a long-term (i.e., longer than 2 years) birth control method unless other options are considered inadequate. (1, 5.1)","NorthStar RxLLC","Provera","REMEDYREPACK INC.","1 INDICATIONS AND USAGE Medroxyprogesterone Acetate Injectable Suspension is indicated for use by females of reproductive potential to prevent pregnancy. Limitations of Use : The use of Medroxyprogesterone Acetate Injectable Suspension is not recommended as a long-term (i.e., longer than 2 years) birth control method unless other options are considered inadequate [see Dosage and Administration (2.1) and Warnings and Precautions ( 5.1 )] . Medroxyprogesterone Acetate Injectable Suspension is a progestin indicated for use by females of reproductive potential to prevent pregnancy. ( 1 ) Limitations of Use: The use of Medroxyprogesterone Acetate Injectable Suspension is not recommended as a long-term (i.e., longer than 2 years) birth control method unless other options are considered inadequate. ( 1 , 5.1 )","Amphastar Pharmaceuticals, Inc.","2021-10-30T13:18:59.963Z")));